Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4014.0
(-0.86%)
JPY 4014.0
(-0.86%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 72.04 Billion JPY | -1.29% |
| 2022 | 72.98 Billion JPY | -4.01% |
| 2021 | 76.03 Billion JPY | 1.41% |
| 2020 | 74.97 Billion JPY | -15.97% |
| 2019 | 89.23 Billion JPY | -5.24% |
| 2018 | 94.16 Billion JPY | -4.33% |
| 2017 | 98.43 Billion JPY | -3.49% |
| 2016 | 101.99 Billion JPY | -6.62% |
| 2015 | 109.21 Billion JPY | 16.32% |
| 2014 | 93.89 Billion JPY | 5.56% |
| 2013 | 88.94 Billion JPY | 2.19% |
| 2012 | 87.04 Billion JPY | -1.08% |
| 2011 | 87.99 Billion JPY | 1.81% |
| 2010 | 86.43 Billion JPY | 1.65% |
| 2009 | 85.02 Billion JPY | 2.53% |
| 2008 | 82.92 Billion JPY | 3.73% |
| 2007 | 79.94 Billion JPY | 4.62% |
| 2006 | 76.41 Billion JPY | 1.18% |
| 2005 | 75.52 Billion JPY | 0.8% |
| 2004 | 74.92 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 18.25 Billion JPY | 4.24% |
| 2023 Q1 | 18.15 Billion JPY | 4.24% |
| 2023 FY | 72.04 Billion JPY | -1.29% |
| 2023 Q4 | 17.35 Billion JPY | -6.24% |
| 2023 Q3 | 18.51 Billion JPY | 2.74% |
| 2023 Q2 | 18.02 Billion JPY | -0.71% |
| 2022 Q4 | 17.41 Billion JPY | -7.16% |
| 2022 Q1 | 18.19 Billion JPY | -0.7% |
| 2022 Q2 | 18.62 Billion JPY | 2.34% |
| 2022 Q3 | 18.75 Billion JPY | 0.71% |
| 2022 FY | 72.98 Billion JPY | -4.01% |
| 2021 Q1 | 18.45 Billion JPY | 3.11% |
| 2021 Q2 | 19.13 Billion JPY | 3.7% |
| 2021 Q3 | 20.12 Billion JPY | 5.15% |
| 2021 Q4 | 18.32 Billion JPY | -8.92% |
| 2021 FY | 76.03 Billion JPY | 1.41% |
| 2020 Q3 | 20.29 Billion JPY | 8.41% |
| 2020 FY | 74.97 Billion JPY | -15.97% |
| 2020 Q2 | 18.71 Billion JPY | 3.59% |
| 2020 Q1 | 18.07 Billion JPY | -5.17% |
| 2020 Q4 | 17.89 Billion JPY | -11.81% |
| 2019 Q4 | 19.05 Billion JPY | -23.8% |
| 2019 Q1 | 22.33 Billion JPY | 3.48% |
| 2019 Q2 | 22.83 Billion JPY | 2.24% |
| 2019 Q3 | 25 Billion JPY | 9.52% |
| 2019 FY | 89.23 Billion JPY | -5.24% |
| 2018 FY | 94.16 Billion JPY | -4.33% |
| 2018 Q4 | 21.58 Billion JPY | -13.89% |
| 2018 Q3 | 25.06 Billion JPY | 7.17% |
| 2018 Q1 | 24.13 Billion JPY | 12.04% |
| 2018 Q2 | 23.38 Billion JPY | -3.1% |
| 2017 Q2 | 24.89 Billion JPY | -0.3% |
| 2017 Q4 | 21.54 Billion JPY | -20.31% |
| 2017 Q3 | 27.03 Billion JPY | 8.59% |
| 2017 Q1 | 24.96 Billion JPY | 8.43% |
| 2017 FY | 98.43 Billion JPY | -3.49% |
| 2016 Q2 | 25.95 Billion JPY | -1.06% |
| 2016 Q3 | 26.78 Billion JPY | 3.22% |
| 2016 Q4 | 23.02 Billion JPY | -14.04% |
| 2016 FY | 101.99 Billion JPY | -6.62% |
| 2016 Q1 | 26.22 Billion JPY | 10.26% |
| 2015 Q3 | 30.45 Billion JPY | 11.4% |
| 2015 Q4 | 23.78 Billion JPY | -21.9% |
| 2015 FY | 109.21 Billion JPY | 16.32% |
| 2015 Q2 | 27.34 Billion JPY | -1.06% |
| 2015 Q1 | 27.63 Billion JPY | 21.52% |
| 2014 Q2 | 22.76 Billion JPY | 6.08% |
| 2014 Q3 | 26.92 Billion JPY | 18.25% |
| 2014 Q4 | 22.74 Billion JPY | -15.54% |
| 2014 FY | 93.89 Billion JPY | 5.56% |
| 2014 Q1 | 21.46 Billion JPY | -2.13% |
| 2013 Q4 | 21.93 Billion JPY | -5.9% |
| 2013 FY | 88.94 Billion JPY | 2.19% |
| 2013 Q1 | 21.27 Billion JPY | 5.08% |
| 2013 Q2 | 22.44 Billion JPY | 5.51% |
| 2013 Q3 | 23.3 Billion JPY | 3.85% |
| 2012 Q2 | 22.74 Billion JPY | 9.44% |
| 2012 FY | 87.04 Billion JPY | -1.08% |
| 2012 Q1 | 20.78 Billion JPY | 0.68% |
| 2012 Q3 | 23.28 Billion JPY | 2.37% |
| 2012 Q4 | 20.24 Billion JPY | -13.06% |
| 2011 Q4 | 20.64 Billion JPY | -12.76% |
| 2011 Q1 | 21.28 Billion JPY | 4.61% |
| 2011 Q2 | 22.4 Billion JPY | 5.29% |
| 2011 Q3 | 23.66 Billion JPY | 5.59% |
| 2011 FY | 87.99 Billion JPY | 1.81% |
| 2010 Q1 | 21.78 Billion JPY | 14.07% |
| 2010 Q4 | 20.34 Billion JPY | -12.35% |
| 2010 Q3 | 23.21 Billion JPY | 10.11% |
| 2010 Q2 | 21.08 Billion JPY | -3.24% |
| 2010 FY | 86.43 Billion JPY | 1.65% |
| 2009 Q2 | 21.31 Billion JPY | 1.4% |
| 2009 Q3 | 23.58 Billion JPY | 10.62% |
| 2009 Q4 | 19.1 Billion JPY | -19.0% |
| 2009 FY | 85.02 Billion JPY | 2.53% |
| 2009 Q1 | 21.02 Billion JPY | 11.82% |
| 2008 Q4 | 18.8 Billion JPY | -18.33% |
| 2008 FY | 82.92 Billion JPY | 3.73% |
| 2008 Q3 | 23.02 Billion JPY | 11.7% |
| 2008 Q2 | 20.61 Billion JPY | 0.0% |
| 2007 FY | 79.94 Billion JPY | 4.62% |
| 2006 FY | 76.41 Billion JPY | 1.18% |
| 2005 FY | 75.52 Billion JPY | 0.8% |
| 2004 FY | 74.92 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -15.925% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 98.31% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 77.097% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 83.441% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -830.99% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 51.405% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 90.287% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -480.719% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 49.16% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 29.976% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -30.029% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -134.305% |
| Tsumura & Co. | 150.84 Billion JPY | 52.24% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | 4.677% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -31.857% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 68.393% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -76.194% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 4.861% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 39.728% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -1329.444% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -53.628% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -1188.869% |
| MedRx Co., Ltd | 26 Million JPY | -276992.308% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -555.557% |
| Solasia Pharma K.K. | 617 Million JPY | -11576.499% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -14.641% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 59.265% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -117788.467% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 95.121% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -225.488% |